Four Years After Fungal Meningitis Outbreak, Compound Pharmacy Safety Concerns Linger

In 2012, a fungal meningitis outbreak was linked to the New England Compounding Center (NECC) in Framingham, Massachusetts, that would eventually lead to more than 750 infections in 20 states and 64 deaths, according to the CDC.

The publicized outbreak thrust compounded medicine into the public eye, prompting many facilities and states to review oversight of quality and safety.

But four years later–and three years after the federal government finalized a law that placed tighter restrictions on the compounding industry–state oversight varies considerably and safety concerns still linger among compounded medications.

This is an excerpt from Patient Safety Monitor Journal. Subscribers can read the full article here. Find out more about the journal, it’s benefits, and how to subscribe by clicking here.